Mitchell Blutt - Nov 23, 2020 Form 4/A - Amendment Insider Report for Consonance-HFW Acquisition Corp. (SRZN)

Role
Director
Signature
/s/Kevin Livingston, Attorney-in-Fact
Stock symbol
SRZN
Transactions as of
Nov 23, 2020
Transactions value $
$24,175
Form type
4/A - Amendment
Date filed
5/19/2021, 06:30 PM
Date Of Original Report
Nov 25, 2020
Previous filing
May 19, 2021
Next filing
May 19, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRZN Class B Ordinary Shares Award $25.2K +3.59M $0.01* 3.59M Sep 4, 2020 See Footnote F2, F6
transaction SRZN Class B Ordinary Shares Disposed to Issuer $0 -719K -20% $0.00 2.88M Oct 8, 2020 See Footnote F2, F6, F7
transaction SRZN Class B Ordinary Shares Disposed to Issuer $0 -575K -20% $0.00 2.3M Nov 10, 2020 See Footnote F2, F6, F7
transaction SRZN Class B Ordinary Shares Sale -$327 -30K -1.3% $0.01* 2.27M Nov 18, 2020 See Footnote F2, F6
transaction SRZN Class B Ordinary Shares Sale -$327 -30K -1.32% $0.01* 2.24M Nov 18, 2020 See Footnote F2, F6
transaction SRZN Class B Ordinary Shares Sale -$327 -30K -1.34% $0.01* 2.21M Nov 18, 2020 See Footnote F2, F6
transaction SRZN Class A Ordinary Shares Award +410K 410K Nov 23, 2020 See Footnote F1, F2, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRZN Warrant Award +137K 137K Nov 23, 2020 Class A Ordinary Shares 137K $11.50 See Footnote F1, F2, F3, F4, F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes securities underlying the 410,000 private placement units of the Issuer purchased by Consonance Life Sciences, LLC (the "Sponsor") for $10.00 per private placement unit. The private placement units were purchased in a private placement that closed simultaneously with the closing of the Issuer's initial public offering. Each unit consists of one Class A ordinary share and one-third of one warrant, with each whole warrant entitling the holder to purchase one Class A ordinary share at $11.50 per share.
F2 The Sponsor is the record holder of the shares and warrants reported herein. The Sponsor is governed by a board of managers consisting of Mitchell J. Blutt, Benny Soffer and Kevin Livingston. As such, Mitchell J. Blutt, Benny Soffer and Kevin Livingston have voting and investment discretion over the shares held by the Sponsor and may be deemed to have shared beneficial ownership of the shares held by the Sponsor. Each of Mitchell J. Blutt, Benny Soffer and Kevin Livingston disclaims beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly.
F3 The warrants will become exercisable on the later of (a) 30 days after the completion of the Issuer's initial business combination or (b) 12 months from the closing of the Issuer's initial public offering.
F4 The warrants will expire five years after the completion of the Issuer's initial business combination.
F5 Includes 136,667 warrants underlying the units referred to in footnote 1.
F6 This Form 4 amendment is being filed to correct the original Form 4 filed on November 25, 2020. The original Form 4 had the incorrect transaction code, and did not include reporting of all of the required transactions.
F7 The Sponsor contributed these shares back to the Issuer for no consideration.